Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFJ4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,661
Award facts
- Contract value 100% obligated
- $26,661.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,661.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors. This competitively awarded, firm fixed price contract with no set-aside designation was executed on December 22, 2025, with an ultimate completion date of December 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts covering a wide spectrum of pharmaceutical products and medical supplies through the Defense Logistics Agency's Medical Supply Chain. Dupixent, a specialty medication used in the treatment of eczema, asthma, and other inflammatory conditions, represents one of many brand-name pharmaceutical products the company supplies to support defense health operations. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing structures, demonstrating the company's capability to meet federal procurement requirements across varying transaction sizes and therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FFJ4L?
SPE2DR26FFJ4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FFJ4L worth?
The government has obligated $26,661 on SPE2DR26FFJ4L.
Is contract SPE2DR26FFJ4L an order under another contract?
Yes. SPE2DR26FFJ4L is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFJ4L competed?
The extent of competition for SPE2DR26FFJ4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award